Fatfish Group Limited (FFTTF PINK) stock market data APIs
$0.0081
0(0%)
as of March 20, 2025
Fatfish Group Limited Financial Data Overview
Fatfish Group Limited is an incubator and venture capital firm specializing in incubation, start-ups and growth stage investments. It invests in the Internet sector with a focus on cryptocurrency, blockchain technologies, technology, internet, and consumer Internet venture. It prefers to take majority controlling stake. Fatfish Group Limited was founded in 2011 and is based in Melbourne, Australia with additional offices in Singapore; Jakarta, Indonesia; and Kuala Lumpur, Malaysia.
Prev. Close
0.0081
Open
0.0081
High
0.0081
Low
0.0081
52 wk Range
0.0046-0.0154
Market Cap
12 662 K
Shares Outstanding
1 554 M
Revenue
1 881 K
EPS
-0.0032
Beta
0.807
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Fatfish Group Limited data using free add-ons & libraries
Get Fatfish Group Limited Fundamental Data
Fatfish Group Limited Fundamental data includes:
- Net Revenue: 1 881 K
- EBITDA: -1 103 381
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Fatfish Group Limited News
New
Evofem Biosciences to Present at H.C. Wainwright Global Life Sciences Conference
SAN DIEGO, Feb. 23, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it will present at the upcoming H.C. Wainwright Global Life Sciences Conference. Evofem's CEO, Saundra...
Evofem Biosciences to Report Fourth Quarter and Year-End 2020 Results and Provide Corporate Update on Thursday, March 4, 2021
-- Conference Call Scheduled for 4:30 p.m. ET -- -- Company to Provide Update on Commercial Launch of Phexxi and Pivotal Phase 3 Trial of EVO100 -- SAN DIEGO, Feb. 18, 2021 /PRNewswire/ -- Evofem Bi...
Evofem Biosciences Launches U.S. Direct-to-Consumer Campaign to Accelerate Awareness of Phexxi®, A Non-Hormonal Birth Control Option for Women
Marketing campaign includes the brand's first-ever commercial spot introducing women to a birth control that puts them in control of their body, their sex life, and their pregnancy prevention. SAN DI...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
